Solriamfetol (SUNOSI, formerly JZP-110 and ADX-N05) is an FDA-approved dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or OSA (obstructive sleep anpoea)
NICE state that:
Notes:
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page